Table of Content


Introduction
Oropharyngeal Cancer - Overview
Oropharyngeal Cancer - Therapeutics Development
Oropharyngeal Cancer - Therapeutics Assessment
Oropharyngeal Cancer - Companies Involved in Therapeutics Development
Oropharyngeal Cancer - Drug Profiles
Oropharyngeal Cancer - Dormant Projects
Oropharyngeal Cancer - Discontinued Products
Oropharyngeal Cancer - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Oropharyngeal Cancer, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Oropharyngeal Cancer, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Oropharyngeal Cancer - Pipeline by AbbVie Inc, H2 2020
Oropharyngeal Cancer - Pipeline by Advaxis Inc, H2 2020
Oropharyngeal Cancer - Pipeline by AMI Onco Theranostics LLC, H2 2020
Oropharyngeal Cancer - Pipeline by Anteris Technologies Ltd, H2 2020
Oropharyngeal Cancer - Pipeline by Ascenta Therapeutics Inc, H2 2020
Oropharyngeal Cancer - Pipeline by Astex Pharmaceuticals Inc, H2 2020
Oropharyngeal Cancer - Pipeline by AstraZeneca Plc, H2 2020
Oropharyngeal Cancer - Pipeline by Atara Biotherapeutics Inc, H2 2020
Oropharyngeal Cancer - Pipeline by Biomimetix JV LLC, H2 2020
Oropharyngeal Cancer - Pipeline by Boehringer Ingelheim International GmbH, H2 2020
Oropharyngeal Cancer - Pipeline by Brooklyn ImmunoTherapeutics LLC, H2 2020
Oropharyngeal Cancer - Pipeline by Dracen Pharmaceuticals Inc, H2 2020
Oropharyngeal Cancer - Dormant Projects, H2 2020
Oropharyngeal Cancer - Discontinued Products, H2 2020